You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Article info

Article menu

Download PDFPDF

XML
Short Report
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Authors

  • Roberta Noseda Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Raffaela Bertoli Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Laura Müller Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Alessandro Ceschi Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland Department of Clinical Pharmacology and ToxicologyUniversity Hospital Zurich Zurich Switzerland PubMed articlesGoogle scholar articles
  1. ↵a +41 91 811 63 00 roberta.noseda{at}eoc.ch
  2. ↵b raffaela.bertoli{at}eoc.ch
  3. ↵c laura.mueller{at}eoc.ch
  4. ↵d alessandro.ceschi{at}eoc.ch
View Full Text

Citation

Noseda R, Bertoli R, Müller L, et al
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports
Journal for ImmunoTherapy of Cancer 2019;7:117. doi: 10.1186/s40425-019-0598-9

Publication history

  • Received December 13, 2018
  • Accepted April 22, 2019
  • First published May 2, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.